.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Daiichi Sankyo
Argus Health
US Department of Justice
Cantor Fitzgerald
Chinese Patent Office
AstraZeneca
Fuji
Healthtrust

Generated: December 13, 2017

DrugPatentWatch Database Preview

NABUMETONE Drug Profile

« Back to Dashboard

When do Nabumetone patents expire, and when can generic versions of Nabumetone launch?

Nabumetone is a drug marketed by Apotex Inc, Chartwell Molecules, Copley Pharm, Dr Reddys Labs Ltd, Impax Labs Inc, Invagen Pharms, Lupin Ltd, Mylan Pharms Inc, Oxford Pharms, Sandoz, and Watson Labs. and is included in twelve NDAs.

The generic ingredient in NABUMETONE is nabumetone. There are twenty drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the nabumetone profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Apotex IncNABUMETONEnabumetoneTABLET;ORAL090427-001Dec 30, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozNABUMETONEnabumetoneTABLET;ORAL075280-001Feb 25, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdNABUMETONEnabumetoneTABLET;ORAL078420-002Sep 24, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell MoleculesNABUMETONEnabumetoneTABLET;ORAL076009-002Jan 24, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lupin LtdNABUMETONEnabumetoneTABLET;ORAL090445-001Jan 12, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozNABUMETONEnabumetoneTABLET;ORAL075280-002Feb 25, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax Labs IncNABUMETONEnabumetoneTABLET;ORAL075189-001May 26, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozNABUMETONEnabumetoneTABLET;ORAL075590-001Feb 25, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Oxford PharmsNABUMETONEnabumetoneTABLET;ORAL079093-001Feb 27, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan Pharms IncNABUMETONEnabumetoneTABLET;ORAL090516-001Jul 12, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Chubb
Federal Trade Commission
Citi
Chinese Patent Office
Cipla
Deloitte
Argus Health
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot